1-179990507-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3

The NM_014810.5(CEP350):​c.121C>G​(p.Leu41Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000721 in 1,386,330 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.2e-7 ( 0 hom. )

Consequence

CEP350
NM_014810.5 missense, splice_region

Scores

2
11
6
Splicing: ADA: 0.9646
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.50

Publications

1 publications found
Variant links:
Genes affected
CEP350 (HGNC:24238): (centrosomal protein 350) The product of this gene is a large protein with a CAP-Gly domain typically found in cytoskeleton-associated proteins. The encoded protein primarily localizes to the centrosome, a non-membraneous organelle that functions as the major microtubule-organizing center in animal cells. The encoded protein directly interacts with another large centrosomal protein and is required to anchor microtubules at the centrosome. It is also implicated in the regulation of a class of nuclear hormone receptors in the nucleus. Several alternatively spliced transcript variants have been found, but their full-length nature has not been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP350NM_014810.5 linkc.121C>G p.Leu41Val missense_variant, splice_region_variant Exon 4 of 38 ENST00000367607.8 NP_055625.4 Q5VT06

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP350ENST00000367607.8 linkc.121C>G p.Leu41Val missense_variant, splice_region_variant Exon 4 of 38 1 NM_014810.5 ENSP00000356579.3 Q5VT06

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000472
AC:
1
AN:
212086
AF XY:
0.00000885
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
7.21e-7
AC:
1
AN:
1386330
Hom.:
0
Cov.:
22
AF XY:
0.00000145
AC XY:
1
AN XY:
689104
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31918
American (AMR)
AF:
0.00
AC:
0
AN:
40386
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25086
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38564
South Asian (SAS)
AF:
0.0000126
AC:
1
AN:
79628
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51742
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5604
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1055568
Other (OTH)
AF:
0.00
AC:
0
AN:
57834
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.675
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 16, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.121C>G (p.L41V) alteration is located in exon 4 (coding exon 3) of the CEP350 gene. This alteration results from a C to G substitution at nucleotide position 121, causing the leucine (L) at amino acid position 41 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.36
BayesDel_addAF
Uncertain
0.087
D
BayesDel_noAF
Benign
-0.11
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0053
T;.
Eigen
Uncertain
0.54
Eigen_PC
Uncertain
0.55
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.89
D;D
M_CAP
Uncertain
0.095
D
MetaRNN
Benign
0.32
T;T
MetaSVM
Uncertain
-0.14
T
MutationAssessor
Uncertain
2.4
M;.
PhyloP100
1.5
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-1.1
N;D
REVEL
Benign
0.28
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
D;.
Vest4
0.58
MutPred
0.28
Gain of MoRF binding (P = 0.0793);.;
MVP
0.63
MPC
0.41
ClinPred
0.88
D
GERP RS
5.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.29
gMVP
0.27
Mutation Taster
=49/51
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
0.96
dbscSNV1_RF
Pathogenic
0.75
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1010215096; hg19: chr1-179959642; API